Page 112 - 先天性心脏病的导管术：从婴幼儿期到成人期

94 先天性心脏病的导管术：从婴幼儿期到成人期

Minich LL, Gray RG. Safety and feasibility of melody transcatheter pulmonary valve

replacement in the native right ventricular outflow tract: a multicenter pediatric heart
network scholar study. JACC Cardiovasc Interv. 2018;11:1642-50.
[9] Sinha S, Aboulhosn J, Asnes J, Bocks M, Zahn E, Goldstein BH, Zampi J, Hellenbrand
W, Salem M, Levi D. Initial results from the off-label use of the SAPIEN S3 valve for

percutaneous transcatheter pulmonary valve replacement: a multi-institutional experi-
ence. Catheter Cardiovasc Interv. 2019;93(3):455-63.
[10] Shahanavaz S, Zahn EM, Levi DS, Aboulhousn JA, Hascoet S, Qureshi AM, Porras D,
Morgan GJ, Bauser Heaton H, Martin MH, Keeshan B, Asnes JD, Kenny D, Ringewald

JM, Zablah JE, Ivy M, Morray BH, Torres AJ, Berman DP, Gillespie MJ, Chaszczewski
K, Zampi JD, Walsh KP, Julien P, Goldstein BH, Sathanandam SK, Karsenty C, Balzer
DT, McElhinney DB. Transcatheter pulmonary valve replacement with the Sapien pros-
thesis. J Am Coll Cardiol. 2020;76:2847-58.

[11] Bergersen L, Benson LN, Gillespie MJ, Cheatham SL, Crean AM, Hor KN, Horlick
EM, Lung TH, McHenry BT, Osten MD, Powell AJ, Cheatham JP. Harmony feasibili-
ty trial: acute and short-term outcomes with a self-expanding transcatheter pulmonary
valve. JACC Cardiovasc Interv. 2017;10(17):1763-73.

[12] Benson LN, Gillespie MJ, Bergersen L, Cheatham SL, Hor KN, Horlick EM, Weng
S, McHenry BT, Osten MD, Powell AJ, Cheatham JP. Three-year outcomes from
the harmony native outflow tract early feasibility study. Circ Cardiovasc Interv.
2020;13(1):e008320. https://doi.org/10.1161/CIRCINTERVENTIONS.119.008320.

[13] Boudjemline Y, Agnoletti G, Bonnet D, Sidi D, Bonhoeffer P. Percutaneous pulmonary
valve replacement in a large right ventricular outflow tract: an experimental study. J Am
Coll Cardiol. 2004;43(6):1082-7.
[14] Shahanavaz S, Balzer D, Babaliaros V, Kim D, Dimas V, Veeram Reddy SR, Leipsic J,

Blanke P, Shirali G, Parthiban A, Gorelick J, Zahn EM. Alterra adaptive prestent and
SAPIEN 3 THV for congenital pulmonic valve dysfunction: an early feasibility study.
JACC Cardiovasc Interv. 2020 Nov 9;13(21):2510-2524. https://doi.org/10.1016/j.
jcin.2020.06.039.

[15] Cao QL, Kenny D, Zhou D, Pan W, Guan L, Ge J, Hijazi ZM. Early clinical experience
with a novel self-expanding percutaneous stent-valve in the native right ventricular out-
flow tract. Catheter Cardiovasc Interv. 2014;84(7):1131-7.
[16] Promphan W, Prachasilchai P, Siripornpitak S, Qureshi SA, Layangool T. Percutaneous